BLK vs XOM: Which Is the Better Buy?

Side-by-side comparison of BlackRock, Inc. and Exxon Mobil Corporation β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-04-22.
BlackRock, Inc. Β· Financial Services
$1,042.85
+125.5% upside to fair value
Grade A High Quality
VS
Exxon Mobil Corporation Β· Energy
$152.30
-33.0% upside to fair value
Med Conviction Grade C+
QuantHub Verdict
BLK has more upside to fair value (+125.5%). XOM trades at a lower forward P/E (17.5x). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric BLK XOM
Current Price $1,042.85 $152.30
Fair Value Estimate $2,351.12 $102.00
Upside to Fair Value +125.5% -33.0%
Market Cap $162.2B $634.6B
Forward P/E 25.9x 17.5x
EV / EBITDA 16.9x 9.8x
Price / Sales 6.3x 2.0x
Price / FCF 45.2x 26.9x
Revenue Growth YoY +28.3% -4.5%
Gross Margin 59.1% 21.7%
Operating Margin 29.9% 10.5%
Return on Equity 12.0% 11.1%
Dividend Yield 0% 2.65%
FCF Yield 2.21% 3.72%
Analyst Consensus Strong Buy Buy
Investment Thesis
BLK β€” BlackRock, Inc.
BlackRock, Inc. is the world's largest asset manager with over $14 trillion in assets under management, operating primarily in financial services and asset management. The company benefits from a durable competitive moat driven by its scale, technology platform Aladdin, and founder-led management with CEO Laurence D. Fink at the helm since inception. BlackRock exhibits strong fundamentals includi…
XOM β€” Exxon Mobil Corporation
Exxon Mobil is a world-class integrated energy supermajor with unmatched Permian Basin scale following the Pioneer Natural Resources acquisition, a high-margin Guyana growth engine, and disciplined capital allocation. However, the stock remains significantly overvalued relative to its own 5-year history on every key metric. At $152, XOM trades at roughly 22x trailing earnings, 1.96x sales, and 27…
Accumulation Zones
Metric BLK XOM
Zone Low $1,763.34 $77.00
Zone High $1,998.45 $92.00
In Buy Zone? Yes No
← BLK Research    XOM Research β†’    All Research